Hence decreased expression of PPARα in PWH is relevant, because PWH are reported to have an increased prevalence of impaired MFO, metabolic syndrome, inflammation, insulin resistance, endothelial dysfunction, and cardiovascular disease [14,15,16,21,22,23,24,25,26,27,28,29,30]. The gene discussed is PPARA; the disease is Insulin resistance.